CUE BIOPHARMA INC (CUE:NASDAQ)
$23.31 1.41 (6.4384%)
Analysed CUE BIOPHARMA INC (CUE:NASDAQ) News Sources
The VIX Sharply Reverses and Points Back Towards 30 After Failed Peace Negotiations
13-04-2026
247wallst.com
Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
15-04-2026
yahoo.com
Cue Biopharma (CUE) Appoints Lucinda Warren as Interim President and CEO
20-04-2026
yahoo.com
Cue Biopharma Announces 1-for-30 Reverse Stock Split
22-04-2026
yahoo.com
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
30-04-2026
yahoo.com
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
30-04-2026
yahoo.com
Cue Biopharma Announces $30 Million Private Placement
30-04-2026
yahoo.com
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07-05-2026
yahoo.com
Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments
14-05-2026
yahoo.com
Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference
21-05-2026
yahoo.com
What is the current price of CUE BIOPHARMA INC (CUE:NASDAQ)?
The current price of CUE BIOPHARMA INC (CUE:NASDAQ) is $23.31.
CUE BIOPHARMA INC (CUE:NASDAQ) absolute price change since previous trading day?
The absolute price change of CUE BIOPHARMA INC (CUE:NASDAQ) since the previous trading day is $1.41.
CUE BIOPHARMA INC (CUE:NASDAQ) percentage price change since previous trading day?
The percentage price change of CUE BIOPHARMA INC (CUE:NASDAQ) since the previous trading day is 6.4384%.
What is the most recent average sentiment score for CUE BIOPHARMA INC (CUE:NASDAQ)?
The most recent average sentiment score for CUE BIOPHARMA INC (CUE:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for CUE BIOPHARMA INC (CUE:NASDAQ)?
The most recent sentiment for CUE BIOPHARMA INC (CUE:NASDAQ) is .
SEC-8K** Filing Available For CUE BIOPHARMA INC (CUE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.